|
1.
|
Wang Z and Chen Z: Acute promyelocytic
leukemia: from highly fatal to highly curable. Blood.
111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Zhou GB, Zhang J, Wang ZY, Chen SJ and
Chen Z: Treatment of acute promyelocytic leukaemia with all-trans
retinoic acid and arsenic trioxide: a paradigm of synergistic
molecular targeting therapy. Philos Trans R Soc Lond B Biol Sci.
362:959–971. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Wang X, Yin Y, Ma P, et al: Apoptosis of
human pancreatic carcinoma cells induced by all-trans retinoic acid
and interferon. Chin J Cancer Res. 21:224–228. 2009. View Article : Google Scholar
|
|
4.
|
Park HH, Kim M, Lee BH, et al:
Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells
and bone marrow T cells in acute leukemia. Ann Clin Lab Sci.
36:7–15. 2006.PubMed/NCBI
|
|
5.
|
Hoyer KK, Herling M, Bagrintseva K, et al:
T cell leukemia-1 modulates TCR signal strength and IFN-gamma
levels through phosphatidylinositol 3-kinase and protein kinase C
pathway activation. J Immunol. 175:864–873. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Montoro E, Lemus D, Echemendia M, et al:
Comparative evaluation of the nitrate reduction assay, the MTT
test, and the resazurin microtitre assay for drug susceptibility
testing of clinical isolates of Mycobacterium tuberculosis.
J Antimicrob Chemother. 55:500–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Huang Y, Liu J, Wang LZ, Zhang WY and Zhu
XZ: Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib
against toxicity of LPS-stimulated macrophages toward motor
neurons. Acta Pharmacol Sin. 26:952–958. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Owen J, Bates J and Lewis S: Differential
effects of nitroblue tetrazolium on the hemodynamic responses
elicited by activation of alpha(1)-adrenoceptors and 5-HT(2)
receptors in conscious rats. Eur J Pharmacol. 535:248–252. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Choi HS, Kim JW, Cha YN and Kim C: A
quantitative nitroblue tetrazolium assay for determining
intracellular superoxide anion production in phagocytic cells. J
Immunoassay Immunochem. 27:31–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Shi J, Zhang Y, Su JY, et al: Cytotoxicity
of IFN-gamma-activated dendritic cells to freshly isolated acute
myeloid leukemia cells. J Exp Hematol. 13:1071–1075.
2005.PubMed/NCBI
|
|
11.
|
Burchert A, Muller MC, Kostrewa P, et al:
Sustained molecular response with interferon alfa maintenance after
induction therapy with imatinib plus interferon alfa in patients
with chronic myeloid leukemia. J Clin Oncol. 28:1429–1435. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Khoo TL, Vangsted AJ, Joshua D and Gibson
J: Interferon-alpha in the treatment of multiple myeloma. Curr Drug
Targets. 12:437–446. 2011.PubMed/NCBI
|
|
13.
|
Benz R, Stussi G and Fehr J: Interferon as
an alternative to purine analogues in the treatment of hairy cell
leukaemia. Brit J Haematol. 148:664–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gupta V, Yi QL, Brandwein J, et al: Role
of all-trans-retinoic acid (ATRA) in the consolidation therapy of
acute promyelocytic leukaemia (APL). Leukemia Res. 29:113–114.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Buonamici S, Li D, Mikhail F, et al: EVI1
abrogates interferon-alpha response by selectively blocking PML
induction. J Biol Chem. 280:428–436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Reineke EL and Kao HY: Targeting
promyelocytic leukemia protein: a means to regulating PML nuclear
bodies. Int Biol Sci. 5:366–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Chelbi-Alix MK, Vidy A, El Bougrini J and
Blondel D: Rabies viral mechanisms to escape the IFN system: the
viral protein P interferes with IRF-3, Stat1, and PML nuclear
bodies. J Interferon Cytokine Res. 26:271–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Crowder C, Dahle O, Davis RE, Gabrielsen
OS and Rudikoff S: PML mediates IFN-alpha-induced apoptosis in
myeloma by regulating TRAIL induction. Blood. 105:1280–1287. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Dror N, Rave-Harel N, Burchert A, et al:
Interferon regulatory factor-8 is indispensable for the expression
of promyelocytic leukemia and the formation of nuclear bodies in
myeloid cells. J Biol Chem. 282:5633–5640. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Bernardi R, Papa A and Pandolfi PP:
Regulation of apoptosis by PML and the PML-NBs. Oncogene.
27:6299–6312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Li L and He DL: Transfection of
promyelocytic leukemia in retrovirus vector inhibits growth of
human bladder cancer cells. Acta Pharmacol Sin. 26:610–615. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ravindranath Y, Gregory J and Feusner J:
Treatment of acute promyelocytic leukemia by using all-trans
retinoic acid (ATRA). Leukemia. 18:1576–1577. 2004.
|
|
23.
|
Gupta V, Yib QL, Brandwein J, et al:
Clinico-biological features and prognostic significance of
PML/RARalpha isoforms in adult patients with acute promyelocytic
leukemia treated with all trans retinoic acid (ATRA) and
chemotherapy. Leuk Lymphoma. 45:469–480. 2004. View Article : Google Scholar
|
|
24.
|
Zhang X, Yan X, Zhou Z, et al: Arsenic
trioxide controls the fate of the PML-RARα oncoprotein by directly
binding PML. Science. 328:240–243. 2010.PubMed/NCBI
|
|
25.
|
Wang ZG, Delva L, Gaboli M, et al: Role of
PML in cell growth and the retinoic acid pathway. Science.
279:1547–1551. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Abreu ELR, Baruffi MR, de Lima AS, et al:
The co-expression of PML/RAR alpha and AML1/ETO fusion genes is
associated with ATRA resistance. Brit J Haematol. 128:407–409.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mueller BU, Pabst T, Fos J, et al: ATRA
resolves the differentiation block in t(15;17) acute myeloid
leukemia by restoring PU. 1 expression. Blood. 107:3330–3338. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Andrianifahanana M, Agrawal A, Singh AP,
et al: Synergistic induction of the MUC4 mucin gene by
interferon-gamma and retinoic acid in human pancreatic tumour cells
involves a reprogramming of signalling pathways. Oncogene.
24:6143–6154. 2005. View Article : Google Scholar
|
|
29.
|
Liu CH: Study on the synergic effect of
all-trans retinoic acid combined with IFN-alpha on the
proliferation and differentiation of HL-60 cells. Chin J Cell Mol
Immunol. 21:637–639. 642:2005.PubMed/NCBI
|
|
30.
|
Gu ZM, Wu YL, Zhou MY, et al: Pharicin B
stabilizes retinoic acid receptor-alpha and presents synergistic
differentiation induction with ATRA in myeloid leukemic cells.
Blood. 116:5289–5297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Wang J, Peng Y, Sun YW, et al: All-trans
retinoic acid induces XAF1 expression through an interferon
regulatory factor-1 element in colon cancer. Gastroenterology.
130:747–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
